Interactions with innate immune cells |
Intestinal epithelial cells (IECs) |
Inhibition of histone deacetylase. Activation of the NLRP3 inflammasome (butyrate only) |
Short-chain fatty acids (acetate, propionate, butyrate) |
Provides energy. Induces goblet cell differentiation and mucus expression. Strengthens tight junctions. Promotes production of IL-18 |
[121, 124–127] |
Activation of the NLRP6 inflammasome |
Taurine |
Enhances epithelial barrier function and production of IL-18 |
[128] |
Activation of FXR |
Secondary bile acids |
Promotes epithelial barrier function |
[129, 130] |
Activation of PXR |
Indole |
Reinforces tight junctions |
[131] |
Unclear. Inhibition of pro-inflammatory cytokines expression |
Polyamines |
Increases production of occludin, zonula occludens 1 and E-cadherin |
[132] |
Innate lymphoid cells (ILCs) |
Activation of AhR |
Indole and indole derivatives |
Promotes expression of IL-22, increasing production of antimicrobial peptides and strengthening intestinal mucosa integrity. Protects against colitis |
[133–136] |
Dendritic cells (DCs) |
Inhibition of histone deacetylase. Binding to the transporter Slc5a8 (propionate and butyrate only) |
Short-chain fatty acids (acetate, propionate, butyrate) |
Inhibits expression of pro-inflammatory cytokines (TNF-α, IL-12 and IFN-γ) and promote production of anti-inflammatory cytokines (IL-10). Inhibits differentiation from bone-marrow precursors and expression of co-stimulatory proteins |
[84, 137–139] |
|
Activation of H2R |
Histamine |
Protects against colitis. Inhibits expression of pro-inflammatory cytokines and the MAPK pathway |
[140] |
|
Activation of GPBAR1 and FXR |
Secondary bile acids |
Inhibits NF-κB-dependent transcription of proinflammatory genes |
[141] |
Neutrophils |
Activation of GPR43. Inhibition of histone deacetylase |
Short-chain fatty acids (acetate, propionate, butyrate) |
Promotes chemotaxis. Suppresses activation of NF-κB and expression of NO. Regulates production of ROS |
[142–145] |
Interactions with adaptive immune cells |
T helper (Th) cells |
Activation of AhR |
Indole-3-lactic acid |
Inhibits polarization of Th17 cells |
[146] |
Activation of H2R or H1R |
Histamine |
Suppresses or promotes Th1 and Th2 polarization |
[147] |
Regulatory T (Treg) cells |
Activation of GPR43 and GPR41. Inhibition of histone deacetylase |
Short-chain fatty acids (acetate, propionate, butyrate) |
Stimulates proliferation. Regulates the mTOR pathway for generation of IL-10 |
[148–150] |
Activation of RAR and RXR heterodimer |
Retinoic acid |
Activates the TGFβ–SMAD pathway. Increases expression of gut-homing markers |
[151, 152] |
Increase expression of the antiapoptotic factor BCL-2 |
Folic acid |
Promotes cell survival |
[153, 154] |
Activation of GPR35, GPR109A and AhR |
Tryptophan metabolites |
Induces differentiation |
[155, 156] |
B cells |
Inhibition of histone deacetylase |
Short-chain fatty acids (acetate, propionate, butyrate) |
Enhances oxidative phosphorylation, glycolysis and fatty acid synthesis. Promotes antibody production |
[157, 158] |
Unclear |
Retinoic acid |
Facilitates IgA class-switch recombination and IgA production |
[159] |